Colonic Diseases, Functional
Irritable Bowel Syndrome
Proton Pump Inhibitors
Histamine H2 Antagonists
Diagnostic Techniques, Digestive System
Drug Therapy, Combination
Why do dyspeptic patients over the age of 50 consult their general practitioner? A qualitative investigation of health beliefs relating to dyspepsia. (1/936)BACKGROUND: The prognosis of late-diagnosed gastric cancer is poor, yet less than half of dyspeptic patients consult their general practitioner (GP). AIM: To construct an explanatory model of the decision to consult with dyspepsia in older patients. METHOD: A total of 75 patients over the age of 50 years who had consulted with dyspepsia at one of two inner city general practices were invited to an in-depth interview. The interviews were taped, transcribed, and analysed using the computer software NUD.IST, according to the principles of grounded theory. RESULTS: Altogether, 31 interviews were conducted. The perceived threat of cancer and the need for reassurance were key influences on the decision to consult. Cues such as a change in symptoms were important in prompting a re-evaluation of the likely cause. Personal vulnerability to serious illness was often mentioned in the context of family or friends' experience, but tempered by an individual's life expectations. CONCLUSION: Most patients who had delayed consultation put their symptoms down to 'old age' or 'spicy food'. However, a significant minority were fatalistic, suspecting the worst but fearing medical interventions. (+info)
The one-stop dyspepsia clinic--an alternative to open-access endoscopy for patients with dyspepsia. (2/936)The most sensitive investigative tool for the upper gastrointestinal tract is endoscopy, and many gastroenterologists offer an open-access endoscopy service to general practitioners. However, for patients with dyspepsia, endoscopy is not always the most appropriate initial investigation, and the one-stop dyspepsia clinic allows for different approaches. We have audited, over one year, the management and outcomes of patients attending a one-stop dyspepsia clinic. All patients seen in the clinic were included, and for those not endoscoped the notes were reviewed one year after the end of the study to check for reattendances and diagnoses originally missed. Patients' and general practitioners' views of the service were assessed by questionnaire. 485 patients were seen, of whom 301 (62%) were endoscoped at first attendance. In 66 patients (14%), endoscopy was deemed inappropriate and only one of these returned subsequently for endoscopy. 118 patients (24%) were symptom-free when seen in the clinic and were asked to telephone for an appointment if and when symptoms recurred; half of these returned and were endoscoped. Oesophagitis and duodenal ulcer were significantly more common in this 'telephone endoscopy' group than in those endoscoped straight from the clinic. Overall, 25% of patients referred were not endoscoped. Important additional diagnoses were made from the clinic consultation. General practitioners and patients valued the system, in particular the telephone endoscopy service. 84% of general practitioners said they would prefer the one-stop dyspepsia clinic to open-access endoscopy. (+info)
Validation of a specific quality of life questionnaire for functional digestive disorders. (3/936)BACKGROUND: Dyspepsia and irritable bowel syndrome are suitable conditions for assessment of quality of life. Their similarities justify the elaboration of a single specific questionnaire for the two conditions. AIMS: To examine the process leading to the validation of the psychometric properties of the functional digestive disorders quality of life questionnaire (FDDQL). METHODS: Initially, the questionnaire was given to 154 patients, to assess its acceptability and reproducibility, analyse its content, and reduce the number of items. Its responsiveness was tested during two therapeutic trials which included 428 patients. The questionnaire has been translated into French, English, and German. The psychometric validation study was conducted in France, United Kingdom, and Germany by 187 practitioners. A total of 401 patients with dyspepsia or irritable bowel syndrome, defined by the Rome criteria, filled in the FDDQL and generic SF-36 questionnaires. RESULTS: The structure of the FDDQL scales was checked by factorial analysis. Its reliability was expressed by a Cronbach's alpha coefficient of 0.94. Assessment of its discriminant validity showed that the more severe the functional digestive disorders, the more impaired the quality of life (p<0.05). Concurrent validity was supported by the correlation found between the FDDQL and SF-36 questionnaire scales. The final version of the questionnaire contains 43 items belonging to eight domains. CONCLUSIONS: The properties of the FDDQL questionnaire, available in French, English, and German, make it appropriate for use in clinical trials designed to evaluate its responsiveness to treatment among patients with dyspepsia and irritable bowel syndrome. (+info)
Relationship between mucosal levels of Helicobacter pylori-specific IgA, interleukin-8 and gastric inflammation. (4/936)Mucosal IgA is important in local immune defence. Helicobacter pylori induces a specific IgA response in antral mucosa, but its immunopathology is unknown. Interleukin-8 (IL-8) has been suggested to be important in H. pylori-induced inflammation. Current information on the relationship between H. pylori-induced IgA and mucosal inflammation is limited. To investigate possible associations between mucosal-specific IgA, the toxinogenicity of H. pylori, mucosal levels of IL-8 and gastric inflammation, 52 endoscoped patients were studied. These comprised 28 patients with peptic ulcer and 24 with non-ulcer dyspepsia. Of these patients, 38 had H. pylori infection: 28 with peptic ulcer and 10 with non-ulcer dyspepsia. Antral biopsies were taken for histology, H. pylori culture and measurement of mucosal levels of IL-8 (pg/mg) and specific IgA (A450x1000) by ELISA. Mucosal H. pylori IgA was detectable in 35 out of 38 patients with H. pylori infection, with a median (interquartile) level of 220 (147, 531) units. There was no significant difference in mucosal levels of the IgA antibodies between patients infected with cytotoxin-positive or cagA-positive strains of H. pylori and those with toxin-negative or cagA-negative strains. The IgA levels in those patients with severe neutrophil infiltration were lower than in those with mild or moderate infiltration (P<0.05). There was a weak inverse correlation between antral mucosal IgA and IL-8 in infected patients (r=-0.36; P=0.04). H. pylori infection induced a significant local mucosal IgA response in most infected patients. The level of IgA antibodies does not appear to be correlated with the toxinogenicity of H. pylori. However, patients with severe active inflammation appear to have decreased levels of IgA. An inverse correlation between mucosal IL-8 and IgA may suggest that IL-8-induced inflammation compromises the mucosal IgA defence and renders the mucosa susceptible to further damage. (+info)
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. (5/936)OBJECTIVES: To determine whether eradication of Helicobacter pylori relieves the symptoms of functional dyspepsia. DESIGN: Multicentre randomised double blind placebo controlled trial. SUBJECTS: 278 patients infected with H pylori who had functional dyspepsia. SETTING: Predominantly secondary care centres in Australia, New Zealand, and Europe. INTERVENTION: Patients randomised to receive omeprazole 20 mg twice daily, amoxicillin 1000 mg twice daily, and clarithromycin 500 mg twice daily or placebo for 7 days. Patients were followed up for 12 months. MAIN OUTCOME MEASURES: Symptom status (assessed by diary cards) and presence of H pylori (assessed by gastric biopsies and 13C-urea breath testing using urea labelled with carbon-13). RESULTS: H pylori was eradicated in 113 patients (85%) in the treatment group and 6 patients (4%) in the placebo group. At 12 months follow up there was no significant difference between the proportion of patients treated successfully by intention to treat in the eradication arm (24%, 95% confidence interval 17% to 32%) and the proportion of patients treated successfully by intention to treat in the placebo group (22%, 15% to 30%). Changes in symptom scores and quality of life did not significantly differ between the treatment and placebo groups. When the groups were combined, there was a significant association between treatment success and chronic gastritis score at 12 months; 41/127 (32%) patients with no or mild gastritis were successfully treated compared with 21/123 (17%) patients with persistent gastritis (P=0. 008). CONCLUSION: No convincing evidence was found that eradication of H pylori relieves the symptoms of functional dyspepsia 12 months after treatment. (+info)
Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. (6/936)BACKGROUND: Serum chromogranin A (CgA) is regarded as a reliable marker of neuroendocrine proliferation. We previously described increased serum CgA levels during short-term profound gastric acid inhibition. AIM: To investigate serum gastrin and CgA levels in dyspeptic patients during continuous medium- (6 weeks to 1 year), or long-term (1-8 years) gastric acid suppressive therapy. PATIENTS AND METHODS: 114 consecutive dyspeptic patients referred for upper gastrointestinal endoscopy were enrolled in a cross-sectional, case-control study [62 patients on continuous antisecretory therapy, either with proton pump inhibitors (n = 47) or H2-receptor antagonists (H2RA) (n = 15) for gastro-oesophageal reflux disease with or without Barrett's oesophagus or functional dyspepsia, and 52 age- and sex-matched patients without medical acid inhibition and with normal endoscopic findings (control group)]. Omeprazole doses ranged from 20 mg to 80 mg daily and ranitidine from 150 mg to 450 mg daily. Fasting serum CgA and serum gastrin levels were measured by radioimmunoassay (reference values: serum CgA < 4.0 nmol/L; serum gastrin < 85 ng/L). RESULTS: Fasting serum CgA levels positively correlated with serum gastrin in the entire study population (r = 0. 55, P = 0.0001). Median serum CgA values were higher in patients treated with a proton pump inhibitor than H2RA [2.8 (2.0-5.9) nmol/L vs. 2 (1.9-2.3) nmol/L, P < 0.002] and controls [2.8 (2.0-5.9) nmol/L vs. 1.8 (1.5-2.2) nmol/L, P < 0.0001) and did not differ between patients treated with H2RA or controls. Serum gastrin and CgA levels in patients on proton pump inhibitor therapy positively correlated with the degree and duration of acid inhibition. Patients on long-term proton pump inhibitor therapy had significantly higher fasting serum gastrin and CgA than those on medium-term proton pump inhibitor therapy [127 (73-217) ng/L vs. 49 (29-78) ng/L, P < 0.0001 and 4.8 (2.8-8) ng/L vs. 2.1 (1.9-2.6) ng/L, P < 0.001]. No such relation was found in patients on medium- vs. long-term H2RA. Overall, patients with positive Helicobacter pylori serology had higher serum gastrin and CgA levels than those with negative H. pylori serology [51 (27-119) ng/L vs. 27 (14-79) ng/L, P = 0.01, 2.4 (1.9-3.4) nmol/L vs. 2.0 (1.7-2.5) nmol/L, P = 0.05]. CONCLUSIONS: During long-term continuous proton pump inhibitor treatment, serum gastrin and CgA levels are significantly elevated compared to H2RA treatment and nontreated dyspeptic controls. H. pylori infection seems to affect gastric ECL cell secretory function. Increased serum CgA values during long-term profound gastric acid inhibition could reflect either gastric enterochromaffin-like cell hyperfunction or proliferative changes. (+info)
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. (7/936)BACKGROUND: There is not at present a suitable disease-specific health-related quality of life instrument for uninvestigated dyspepsia and functional (non-ulcer) dyspepsia. AIM: To develop a new multi-dimensional disease-specific instrument. METHODS: The Nepean Dyspepsia Index (NDI) was designed to measure impairment of a subject's ability to engage in relevant aspects of their life and also their enjoyment of these aspects; in addition, the individual importance of each aspect is assessed. A 42-item quality of life measure was developed and tested, both in out-patients presenting to general practice with upper gastrointestinal complaints (n = 113) and in a randomly chosen population-based sample (n = 347). RESULTS: Adequate face and content validity was documented by an expert panel. Factor analysis identified four clinically relevant subscales: interference with activities of daily living, work, enjoyment of life and emotional well-being; lack of knowledge and control over the illness; disturbance to eating or drinking; and disturbance to sleep because of dyspepsia. These scales had high internal consistency. Both symptoms and the quality of life scores discriminated dyspepsia from health. CONCLUSION: The Nepean Dyspepsia Index is a reliable and valid disease-specific index for dyspepsia, measuring symptoms and health-related quality of life. (+info)
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. (8/936)BACKGROUND: A furazolidone-containing therapeutic regimen for Helicobacter pylori infection has attracted special interest in the face of a rising world-wide metronidazole resistant H. pylori, and the expense of currently used antimicrobial regimens. AIM: To evaluate the efficacy of furazolidone-containing regimens in eradicating H. pylori. METHODS: One-hundred and forty H. pylori positive patients with endoscopically confirmed duodenal ulcer or functional dyspepsia received one of four different regimens to eradicate H. pylori. In the first trial, the patients were randomly assigned to receive a 1-week course of furazolidone 100 mg b.d. and clarithromycin 250 mg b.d., with either tripotassium dicitrato bismuthate (TDB) 240 mg b.d. (FCB group) or lansoprazole 30 mg daily (FCL group). In the second trial, the patients were randomly assigned to receive a 1-week course of clarithromycin 250 mg b.d. and omeprazole 20 mg daily, with either furazolidone 100 mg b.d. (FCO group) or metronidazole 400 mg b.d. (MCO group). Endoscopy was repeated 4 weeks following completion of therapy with re-assessment of H. pylori status on gastric biopsies by histology and culture. RESULTS: Four patients (1 in FCB, 1 in FCO and 2 in MCO groups) dropped out because they refused a follow-up endoscopy. Eradication rates of H. pylori on an intention-to-treat basis in the FCB, FCL, FCO and MCO groups were 91% (32/35, 95% CI: 82-99%), 91% (32/35, CI: 82-99%), 86% (30/35, CI: 74-97%) and 74% (26/35, CI: 60-89%) (all P > 0.05), respectively. Mild side-effects occurred in 15% of the 140 patients. In MCO group, the eradication rate in the patients infected with metronidazole-sensitive isolates of H. pylori was 86%, but dropped to 67% in those with metronidazole-resistance strains (P = 0.198). CONCLUSION: One-week regimens containing furazolidone and clarithromycin in combination with TDB or a proton pump inhibitor fulfil the criteria for successful H. pylori therapy. (+info)
Dyspepsia is not a specific disease but rather a symptom complex that can be caused by a variety of factors, such as:
1. Gastritis (inflammation of the stomach lining)
2. Peptic ulcer
3. Gastroesophageal reflux disease (GERD)
4. Functional dyspepsia
5. Inflammatory conditions such as Crohn's disease or ulcerative colitis
6. Food allergies or intolerances
7. Hormonal changes during pregnancy or menstruation
8. Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics
The diagnosis of dyspepsia is based on a combination of medical history, physical examination, and diagnostic tests such as endoscopy, gastric emptying studies, and blood tests. Treatment depends on the underlying cause of dyspepsia and may include medications, lifestyle changes, and dietary modifications.
1. Gastritis: Inflammation of the stomach lining, which can be acute or chronic.
2. Peptic ulcer disease: Ulcers in the stomach or duodenum (the first part of the small intestine) that are caused by H. pylori infection.
3. Gastric adenocarcinoma: A type of stomach cancer that is associated with long-term H. pylori infection.
4. Mucosa-associated lymphoid tissue (MALT) lymphoma: A rare type of cancer that affects the immune cells in the stomach and small intestine.
5. Gastroesophageal reflux disease (GERD): A condition in which stomach acid flows back up into the esophagus, causing symptoms such as heartburn and regurgitation.
6. Helicobacter pylori-associated chronic atrophic gastritis: A type of chronic inflammation of the stomach lining that can lead to stomach ulcers and stomach cancer.
7. Post-infectious irritable bowel syndrome (PI-IBS): A condition that develops after a gastrointestinal infection, characterized by persistent symptoms such as abdominal pain, bloating, and changes in bowel habits.
Helicobacter infections are typically diagnosed through endoscopy, where a flexible tube with a camera and light on the end is inserted into the stomach and small intestine to visualize the mucosa and look for signs of inflammation or ulcers. Laboratory tests such as breath tests and stool tests may also be used to detect the presence of H. pylori bacteria in the body. Treatment typically involves a combination of antibiotics and acid-suppressing medications to eradicate the infection and reduce symptoms.
Preventing Helicobacter Infections:
While it is not possible to completely prevent Helicobacter infections, there are several measures that can be taken to reduce the risk of developing these conditions:
1. Practice good hygiene: Wash your hands regularly, especially before eating and after using the bathroom.
2. Avoid close contact with people who have Helicobacter infections.
3. Avoid sharing food, drinks, or utensils with people who have Helicobacter infections.
4. Avoid consuming undercooked meat, especially pork and lamb.
5. Avoid consuming raw shellfish, especially oysters.
6. Avoid consuming unpasteurized dairy products.
7. Avoid alcohol and caffeine, which can irritate the stomach lining and increase the risk of developing Helicobacter infections.
8. Maintain a healthy diet that is high in fiber and low in fat.
9. Manage stress, as stress can exacerbate symptoms of Helicobacter infections.
10. Practice good oral hygiene to prevent gum disease and other oral infections that can increase the risk of developing Helicobacter infections.
Helicobacter infections are a common cause of stomach ulcers, gastritis, and other gastrointestinal disorders. These infections are caused by the bacteria Helicobacter pylori, which can be found in the stomach lining and small intestine. While these infections can be difficult to diagnose, a combination of endoscopy, blood tests, and stool tests can help confirm the presence of Helicobacter bacteria. Treatment typically involves a combination of antibiotics and acid-suppressing medications to eradicate the infection and reduce symptoms. Preventive measures include practicing good hygiene, avoiding close contact with people who have Helicobacter infections, and maintaining a healthy diet.
A peptic ulcer is a break in the lining of the stomach or duodenum (the first part of the small intestine), which can cause pain and bleeding. The stomach acid and digestive enzymes flowing through the ulcer can irritate the surrounding tissue, leading to inflammation and discomfort.
Peptic ulcers are commonly caused by an infection with Helicobacter pylori (H. pylori) bacteria or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or aspirin. Other contributing factors include stress, smoking, and excessive alcohol consumption.
Symptoms of a peptic ulcer may include abdominal pain, nausea, vomiting, and loss of appetite. Treatment options typically involve antibiotics to eradicate H. pylori infection or stopping NSAID use, along with medications to reduce acid production in the stomach and protect the ulcer from further damage. Surgery may be necessary for severe cases or if other treatments fail.
Prevention methods include avoiding NSAIDs, maintaining a healthy lifestyle, managing stress, and getting regular screenings for H. pylori infection. Early detection and proper treatment can help alleviate symptoms and prevent complications such as ulcer perforation or bleeding.
In summary, peptic ulcers are painful and potentially harmful conditions that can be caused by various factors. Proper diagnosis and treatment are essential to prevent complications and improve quality of life.
Types of Gastrointestinal Diseases:
1. Irritable Bowel Syndrome (IBS): A common condition characterized by abdominal pain, bloating, and changes in bowel movements.
2. Inflammatory Bowel Disease (IBD): A group of chronic conditions that cause inflammation in the digestive tract, including Crohn's disease and ulcerative colitis.
3. Gastroesophageal Reflux Disease (GERD): A condition in which stomach acid flows back into the esophagus, causing heartburn and other symptoms.
4. Peptic Ulcer Disease: A condition characterized by ulcers in the lining of the stomach or duodenum.
5. Diverticulitis: A condition in which small pouches form in the wall of the colon and become inflamed.
6. Gastritis: Inflammation of the stomach lining, often caused by infection or excessive alcohol consumption.
7. Esophagitis: Inflammation of the esophagus, often caused by acid reflux or infection.
8. Rectal Bleeding: Hemorrhage from the rectum, which can be a symptom of various conditions such as hemorrhoids, anal fissures, or inflammatory bowel disease.
9. Functional Dyspepsia: A condition characterized by recurring symptoms of epigastric pain, bloating, nausea, and belching.
10. Celiac Disease: An autoimmune disorder that causes the immune system to react to gluten, leading to inflammation and damage in the small intestine.
Causes of Gastrointestinal Diseases:
1. Infection: Viral, bacterial, or parasitic infections can cause gastrointestinal diseases.
2. Autoimmune Disorders: Conditions such as Crohn's disease and ulcerative colitis occur when the immune system mistakenly attacks healthy tissue in the GI tract.
3. Diet: Consuming a diet high in processed foods, sugar, and unhealthy fats can contribute to gastrointestinal diseases.
4. Genetics: Certain genetic factors can increase the risk of developing certain gastrointestinal diseases.
5. Lifestyle Factors: Smoking, excessive alcohol consumption, stress, and lack of physical activity can all contribute to gastrointestinal diseases.
6. Radiation Therapy: Exposure to radiation therapy can damage the GI tract and increase the risk of developing certain gastrointestinal diseases.
7. Medications: Certain medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids can cause gastrointestinal side effects.
Aerophagy can be caused by a variety of factors such as eating too quickly or not chewing food properly, swallowing air while drinking carbonated beverages or eating with straws, or having a condition that affects the digestive system such as irritable bowel syndrome (IBS).
The symptoms of aerophagy can vary depending on the individual and the amount of air swallowed. Some common symptoms include abdominal pain, bloating, gas, discomfort, and difficulty burping or passing gas. In severe cases, aerophagy can lead to more serious complications such as bowel obstruction or perforation, which can be life-threatening.
Treatment for aerophagy usually involves avoiding activities that cause air swallowing, eating slowly and chewing food properly, and using over-the-counter medications to relieve symptoms such as antacids or gas relief medications. In severe cases, medical treatment may be necessary to manage complications such as bowel obstruction or perforation.
In conclusion, aerophagy is a rare condition that can cause abdominal pain and discomfort due to the accumulation of swallowed air in the stomach and intestines. Treatment usually involves avoiding activities that cause air swallowing and using over-the-counter medications to relieve symptoms, while severe cases may require medical treatment to manage complications.
Symptoms of gastritis may include abdominal pain, nausea, vomiting, loss of appetite, and difficulty swallowing. In severe cases, bleeding may occur in the stomach and black tarry stools may be present.
Diagnosis of gastritis is typically made through endoscopy, during which a flexible tube with a camera and light on the end is inserted through the mouth to visualize the inside of the stomach. Biopsies may also be taken during this procedure to examine the stomach tissue under a microscope for signs of inflammation or infection.
Treatment of gastritis depends on the underlying cause, but may include antibiotics for bacterial infections, anti-inflammatory medications, and lifestyle modifications such as avoiding alcohol, losing weight, and eating smaller more frequent meals. In severe cases, surgery may be necessary to remove damaged tissue or repair any ulcers that have developed.
Functional colonic diseases include:
1. Irritable Bowel Syndrome (IBS): A common condition characterized by recurring abdominal pain, bloating, and changes in bowel habits (diarrhea or constipation).
2. Functional dyspepsia: A condition characterized by recurring symptoms of epigastric pain, discomfort, bloating, and nausea, without any identifiable organic cause.
3. Functional constipation: A condition characterized by infrequent bowel movements, hard or difficult-to-pass stools, and sensation of incomplete evacuation.
4. Functional diarrhea: A condition characterized by frequent, loose, and watery bowel movements.
5. Functional abdominal pain: Recurring abdominal pain without any identifiable organic cause.
The exact causes of functional colonic diseases are not fully understood, but they are thought to be related to abnormalities in the functioning of the enteric nervous system, immune system, and gut microbiome. These conditions are often associated with stress, dietary factors, and other lifestyle factors.
The diagnosis of functional colonic diseases is based on a combination of clinical symptoms, physical examination, and laboratory tests (such as stool studies and gastrointestinal imaging). Treatment typically involves lifestyle modifications (such as dietary changes and stress management) and medications (such as antispasmodics, antidepressants, and laxatives) to manage symptoms and improve quality of life.
GER can be caused by a variety of factors, including:
* Weakening of the lower esophageal sphincter (LES), which allows stomach acid to flow back up into the esophagus.
* Delayed gastric emptying, which can cause food and stomach acid to remain in the stomach for longer periods of time and increase the risk of reflux.
* Obesity, which can put pressure on the stomach and cause the LES to weaken.
Symptoms of GER can include:
* Heartburn: a burning sensation in the chest that can radiate to the throat and neck.
* Regurgitation: the sensation of food coming back up into the mouth.
* Difficulty swallowing.
* Chest pain or tightness.
* Hoarseness or laryngitis.
If left untreated, GER can lead to complications such as esophagitis (inflammation of the esophagus), strictures (narrowing of the esophagus), and barrett's esophagus (precancerous changes in the esophageal lining).
Treatment options for GER include:
* Lifestyle modifications, such as losing weight, avoiding trigger foods, and elevating the head of the bed.
* Medications, such as antacids, H2 blockers, and proton pump inhibitors, to reduce acid production and relax the LES.
* Surgical procedures, such as fundoplication (a procedure that strengthens the LES) and laparoscopic adjustable gastric banding (a procedure that reduces the size of the stomach).
It is important to seek medical attention if symptoms persist or worsen over time, as GER can have serious complications if left untreated.
The main causes of duodenal ulcers are:
1. Infection with the bacterium Helicobacter pylori (H. pylori)
2. Overuse of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, and naproxen
3. Excessive alcohol consumption
5. Zollinger-Ellison syndrome, a rare condition that causes the stomach to produce too much acid
Symptoms of duodenal ulcers may include:
1. Abdominal pain, which can be worse when eating or at night
2. Nausea and vomiting
3. Bloating and gas
4. Acid reflux
5. Weight loss
Diagnosis of a duodenal ulcer typically involves a combination of endoscopy, where a flexible tube with a camera is inserted through the mouth to visualize the inside of the digestive tract, and breath tests to detect H. pylori infection.
Treatment for duodenal ulcers usually involves eradication of H. pylori infection, if present, and avoidance of NSAIDs and other irritants. Antacids or acid-suppressing medications may also be prescribed to help reduce symptoms and allow the ulcer to heal. In severe cases, surgery may be necessary.
Prevention of duodenal ulcers includes:
1. Avoiding NSAIDs and other irritants
2. Eradicating H. pylori infection
3. Quitting smoking and excessive alcohol consumption
4. Managing stress
5. Eating a healthy diet with plenty of fruits, vegetables, and whole grains
Prognosis for duodenal ulcers is generally good if treated promptly and effectively. However, complications such as bleeding, perforation, and obstruction can be serious and potentially life-threatening. It is important to seek medical attention if symptoms persist or worsen over time.
In conclusion, duodenal ulcers are a common condition that can cause significant discomfort and disrupt daily life. While they can be caused by a variety of factors, H. pylori infection is the most common underlying cause. Treatment typically involves eradication of H. pylori infection, avoidance of NSAIDs and other irritants, and management of symptoms with antacids or acid-suppressing medications. Prevention includes avoiding risk factors and managing stress. With prompt and effective treatment, the prognosis for duodenal ulcers is generally good. However, complications can be serious and potentially life-threatening, so it is important to seek medical attention if symptoms persist or worsen over time.
There are several subtypes of IBS, including:
* IBS-C (constipation-predominant)
* IBS-D (diarrhea-predominant)
* IBS-M (mixed)
The symptoms of IBS can vary in severity and frequency from person to person, and may include:
* Abdominal pain or cramping
* Diarrhea or constipation
* Mucus in the stool
* Feeling of incomplete evacuation after bowel movements
There is no cure for IBS, but symptoms can be managed with dietary changes, stress management techniques, and medications such as fiber supplements, antispasmodics, and antidepressants. It is important to seek medical advice if symptoms persist or worsen over time, as IBS can have a significant impact on quality of life and may be associated with other conditions such as anxiety or depression.
The causes of abdominal pain are numerous and can include:
1. Gastrointestinal disorders: Ulcers, gastritis, inflammatory bowel disease, diverticulitis, and appendicitis.
2. Infections: Urinary tract infections, pneumonia, meningitis, and sepsis.
3. Obstruction: Blockages in the intestines or other hollow organs.
4. Pancreatic disorders: Pancreatitis and pancreatic cancer.
5. Kidney stones or other kidney disorders.
6. Liver disease: Hepatitis, cirrhosis, and liver cancer.
7. Hernias: Inguinal hernia, umbilical hernia, and hiatal hernia.
8. Splenic disorders: Enlarged spleen, splenic rupture, and splenectomy.
9. Cancer: Colorectal cancer, stomach cancer, pancreatic cancer, and liver cancer.
10. Reproductive system disorders: Ectopic pregnancy, ovarian cysts, and testicular torsion.
The symptoms of abdominal pain can vary depending on the underlying cause, but common symptoms include:
* Localized or generalized pain in the abdomen
* Cramping or sharp pain
* Difficulty breathing or swallowing
* Nausea and vomiting
* Diarrhea or constipation
* Fever and chills
* Abdominal tenderness or guarding (muscle tension)
Abdominal pain can be diagnosed through a variety of methods, including:
1. Physical examination and medical history
2. Imaging studies such as X-rays, CT scans, and MRI scans
3. Blood tests and urinalysis
4. Endoscopy and laparoscopy
Treatment for abdominal pain depends on the underlying cause, but may include:
1. Medications such as antibiotics, anti-inflammatory drugs, and pain relievers
2. Surgery to repair hernias or remove tumors
3. Endoscopy to remove blockages or treat ulcers
4. Supportive care such as intravenous fluids and oxygen therapy
5. Lifestyle modifications such as dietary changes and stress management techniques.
The symptoms of heartburn can vary from person to person, but typically include:
* A burning sensation in the chest and throat
* Regurgitation of food
* Difficulty swallowing
* Coughing or wheezing
* Chest pain or discomfort
Heartburn is caused by a weakening of the lower esophageal sphincter (LES), which allows stomach acid to flow back up into the esophagus. This can be triggered by a variety of factors, including:
* Eating certain types of foods (e.g. citrus fruits, tomatoes, chocolate)
* Drinking alcohol or caffeine
* Being overweight or obese
* Certain medications (e.g. NSAIDs, theophylline)
If left untreated, heartburn can lead to complications such as:
* Esophagitis (inflammation of the esophagus)
* Ulcers in the esophagus or stomach
* Scarring of the esophagus
* Barrett's esophagus (precancerous changes in the esophagus)
Treatment for heartburn typically involves lifestyle modifications, such as:
* Avoiding trigger foods and drinks
* Eating smaller, more frequent meals
* Losing weight
* Avoiding tight clothing that can exacerbate the condition
* Elevating the head of the bed
* Reducing stress through relaxation techniques (e.g. meditation, deep breathing)
In addition to lifestyle modifications, medications such as antacids, H2 blockers, and proton pump inhibitors may be prescribed to help manage heartburn symptoms. In severe cases, surgery may be necessary to repair any damage to the esophagus or stomach.
Preventing heartburn involves making lifestyle changes and avoiding triggers that can exacerbate the condition. Some strategies for preventing heartburn include:
* Avoiding trigger foods and drinks (e.g. citrus fruits, tomatoes, chocolate, caffeine, alcohol)
* Eating smaller, more frequent meals
* Losing weight if overweight or obese
* Avoiding tight clothing that can exacerbate the condition
* Elevating the head of the bed
* Reducing stress through relaxation techniques (e.g. meditation, deep breathing)
* Quitting smoking and avoiding secondhand smoke
* Avoiding certain medications (e.g. NSAIDs, theophylline) that can exacerbate heartburn symptoms.
It is important to note that while heartburn can be uncomfortable and disrupt daily life, it is generally not a serious condition. However, if symptoms persist or worsen over time, it is important to seek medical attention to rule out any underlying conditions that may need more urgent treatment.
Gastroparesis can lead to complications such as malnutrition, dehydration, and electrolyte imbalances if left untreated. Treatment options for gastroparesis include medications to slow gastric emptying, antidepressants, anti-nausea drugs, and in severe cases, surgery or gastric pacemakers may be considered.
In some cases, gastroparesis can be a symptom of an underlying condition such as fibromyalgia or chronic fatigue syndrome. It is important for individuals experiencing persistent gastrointestinal symptoms to consult with a healthcare professional for proper diagnosis and treatment.
Bile Reflux | Symptoms, Causes, Treatments | American ...
There are many different types of stomach diseases, some of which include:
1. Gastritis: This is inflammation of the stomach lining, which can be caused by infection, autoimmune disorders, or excessive alcohol consumption.
2. Peptic ulcer: This is a sore on the lining of the stomach or duodenum (the first part of the small intestine). Peptic ulcers are often caused by infection with the bacterium Helicobacter pylori, but they can also be caused by excessive acid production.
3. Gastroesophageal reflux disease (GERD): This is a condition in which stomach acid flows back up into the esophagus, causing symptoms such as heartburn and difficulty swallowing.
4. Stomach cancer: This is a type of cancer that affects the stomach lining, and it can be caused by a variety of factors including age, diet, and family history.
5. Inflammatory bowel disease (IBD): This is a chronic condition that causes inflammation in the digestive tract, including the stomach. Crohn's disease and ulcerative colitis are examples of IBD.
6. Gastrointestinal motility disorders: These are conditions that affect the muscles and nerves of the digestive system, causing problems with movement and contraction of the stomach and intestines.
7. Stomach polyps: These are growths on the lining of the stomach that can be benign or cancerous.
8. Hiatal hernia: This is a condition in which part of the stomach bulges up into the chest through a hole in the diaphragm, which can cause symptoms such as heartburn and difficulty swallowing.
9. Gastroesophageal reflux disease (GERD): This is a chronic form of acid reflux that can cause symptoms such as heartburn and difficulty swallowing.
10. Zollinger-Ellison syndrome: This is a rare condition that causes the stomach to produce too much acid, leading to symptoms such as heartburn, nausea, and vomiting.
These are just some of the many possible causes of stomach pain. It's important to see a doctor if you experience persistent or severe stomach pain, especially if it is accompanied by other symptoms such as fever, bleeding, or difficulty swallowing. Your doctor can perform tests and examinations to determine the cause of your stomach pain and recommend appropriate treatment.
In medical terminology, "itis" is a suffix that indicates inflammation or infection. Therefore, duodenitis specifically refers to the inflammation of the duodenum.
Examples of medical conditions that may cause duodenitis include:
* Viral or bacterial infections
* Autoimmune disorders such as Crohn's disease or ulcerative colitis
* Gut injury due to trauma, surgery, or burns
* Radiation therapy or chemotherapy
Duodenitis can be diagnosed through various medical tests such as:
* Endoscopy: A flexible tube with a camera and light on the end is inserted through the mouth and into the duodenum to visualize the inside of the digestive tract.
* Biopsy: A small sample of tissue is taken from the duodenum for examination under a microscope.
* Blood tests: To check for signs of infection or inflammation, such as elevated white blood cell count or liver enzymes.
Treatment options for duodenitis depend on the underlying cause and severity of the condition. Some possible treatment options include:
* Antibiotics to treat bacterial infections
* Anti-inflammatory medications such as corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain.
* Dietary modifications, such as avoiding trigger foods or taking probiotics to promote gut health.
* Stress management techniques, such as relaxation exercises or cognitive behavioral therapy, to help manage symptoms of stress-related duodenitis.
* Surgery may be necessary in severe cases or if other treatments are not effective.
It is important to seek medical attention if you experience persistent or severe abdominal pain, as duodenitis can be a sign of a more serious underlying condition. A healthcare professional can help determine the cause and develop an appropriate treatment plan.
Esophagitis can be acute or chronic, and it can affect people of all ages. Acute esophagitis is a short-term inflammation that can be caused by a viral or bacterial infection, while chronic esophagitis can last for weeks or months and may be caused by ongoing exposure to irritants such as stomach acid or allergens.
Esophagitis can lead to complications such as narrowing of the esophagus, stricture, or ulcers, which can make it difficult to swallow and can lead to malnutrition and weight loss. In severe cases, esophagitis can also lead to life-threatening complications such as perforation or bleeding.
Esophagitis is diagnosed through a combination of endoscopy, imaging tests such as CT scans or MRI, and laboratory tests such as blood tests or biopsies. Treatment for esophagitis depends on the underlying cause, but may include antibiotics, anti-inflammatory medications, and lifestyle changes such as avoiding trigger foods or drinks. In severe cases, surgery may be necessary to repair any damage to the esophagus.
Esophagitis is a common condition that affects millions of people worldwide, and it can have a significant impact on quality of life. While there are several effective treatment options available, prevention is often the best approach, and this involves making lifestyle changes such as avoiding trigger foods or drinks, managing gastroesophageal reflux disease (GERD), and practicing good hygiene to avoid infections. With proper diagnosis and treatment, most people with esophagitis can experience significant improvement in symptoms and quality of life.
Stomach ulcers are caused by an imbalance between the acid and mucus in the stomach, which can lead to inflammation and damage to the stomach lining. Factors that can contribute to the development of a stomach ulcer include:
* Infection with the bacterium Helicobacter pylori (H. pylori)
* Overuse of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, and naproxen
* Excessive alcohol consumption
* Zollinger-Ellison syndrome, a rare condition that causes the stomach to produce too much acid.
Symptoms of a stomach ulcer may include:
* Pain in the upper abdomen, often described as a burning or gnawing sensation
* Nausea and vomiting
* Bloating and gas
* Abdominal tenderness
* Loss of appetite
* Weight loss
Treatment for stomach ulcers typically involves antibiotics to kill H. pylori, if present, and acid-suppressing medications to reduce the amount of acid in the stomach. In severe cases, surgery may be necessary. Lifestyle changes, such as avoiding NSAIDs, alcohol, and smoking, can also help manage symptoms and prevent recurrence.
Preventive measures for stomach ulcers include:
* Avoiding NSAIDs and other irritating substances
* Using acid-suppressing medications as needed
* Maintaining a healthy diet and lifestyle
* Managing stress
* Avoiding excessive alcohol consumption
It is important to seek medical attention if symptoms persist or worsen over time, as stomach ulcers can lead to complications such as bleeding, perforation, and obstruction. Early diagnosis and treatment can help prevent these complications and improve outcomes.
There are several possible causes of flatulence, including:
1. Eating certain types of food, such as beans, cabbage, and broccoli, that are difficult for the body to digest
2. Swallowing air, which can occur when eating or drinking too quickly
3. A condition called irritable bowel syndrome (IBS), which affects the large intestine
4. A food intolerance, such as lactose intolerance or gluten intolerance
5. Gastrointestinal infections, such as giardiasis or amoebiasis
6. Hormonal changes, such as during pregnancy or menstruation
7. Medications, such as antibiotics and chemotherapy drugs
8. Other medical conditions, such as diabetes, liver disease, and kidney disease.
Flatulence can cause a range of symptoms, including:
1. Gas and bloating in the abdomen
2. Pain or discomfort in the abdomen
3. Passing wind or farting
4. Abdominal cramps
5. Diarrhea or constipation
6. Nausea and vomiting
While flatulence is generally not a serious condition, it can be embarrassing and disruptive to daily life. Treatment for flatulence depends on the underlying cause and may include dietary changes, over-the-counter medications, or medical treatment for any underlying conditions.
Charlotte Perkins Gilman
Magnesium (medical use)
Functional gastrointestinal disorder
List of adverse effects of olanzapine
Jackson Springs, North Carolina
List of patient-reported quality of life surveys
Red Boiling Springs, Tennessee
Justus Cornelius Ramsey
Esophageal pH monitoring
Joseph Honoré Simon Beau
Indigestion (Dyspepsia) - NIDDK
Indigestion | Dyspepsia | MedlinePlus
Browsing by Subject "Dyspepsia"
Efficacy of cisapride therapy in functional dyspepsia - PubMed
Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump...
Subjects: Dyspepsia - Digital Collections - National Library of Medicine Search Results
Inasertive behavior in functional dyspepsia
Dyspepsia Diet - Health Hearty
13 Highlights From ACG 2022
Details for: Functional dyspepsia : › WHO HQ Library catalog
Aldioxa improves delayed gastric emptying and impaired gastric compliance, pathophysiologic mechanisms of functional dyspepsia<...
IMSEAR at SEARO: Appendicular dyspepsia due to stones (foreign body).
purchase Generic Bentyl Canada, Bentyl for dyspepsia - BEING AFRICAN
Dyspepsia Treatment, Belching Treatment, Homeopathic Remedy For Constipation - HomeopathicProduct.com
Smaller CO2 injection volume and lower gastric pressure induce bothersome symptoms in drug-resistant functional dyspepsia...
The invalid's guide, and consumptive's manual: or suggestions for the prevention and relief of consumption, asthma, catarrh,...
Pennyroyal: MedlinePlus Supplements
Gastric Dumping - Glossary Definition
P RXQ RX
Course Content - #98030: Getting to the Point: Acupuncture and Acupoint Therapies - NetCE
Familial Trichostrongylus Infection Misdiagnosed as Acute Fascioliasis - Volume 21, Number 10-October 2015 - Emerging...
Enablex (Darifenacin Extended-Release Tablets): Uses, Dosage, Side Effects, Interactions, Warning
Entacapone Tablets, USP Rx Only Prescribing Information
DailyMed - FESOTERODINE FUMARATE tablet, film coated, extended release
Conditions We Treat | Neurogastroenterology and Motility Disorders
DailyMed - NERLYNX- neratinib tablet
- The term 'dyspepsia' is used for indigestion in the medical parlance. (healthhearty.com)
Functional dyspepsia patients2
- Smaller CO2 injection volume and lower gastric pressure induce bothersome symptoms in drug-resistant functional dyspepsia patients with less frequent belching. (bvsalud.org)
- Influence of Acupuncture Treatment on Cerebral Activity in Functional Dyspepsia Patients and Its Relationship With Efficacy. (qigonginstitute.org)
- To assess the efficacy of cisapride therapy in relieving symptoms of functional dyspepsia. (nih.gov)
- Delayed gastric emptying and impaired gastric accommodation (decreased gastric compliance) play important roles in functional dyspepsia (FD). (elsevier.com)
- Dyspepsia diet is recommended to those affected by a stomach condition called dyspepsia. (healthhearty.com)
- Acupuncture is a commonly used therapy for treating functional dyspepsia (FD), although the mechanism remains unclear. (qigonginstitute.org)
- When the pain and discomfort remains for a longer duration it's called chronic disorder and it's referred as functional dyspepsia. (healthhearty.com)
- This is an excellent homeopathic remedy for dyspepsia treatment. (homeopathicproduct.com)
Functional dyspepsia remains3
- the Rome III redefinition of functional dyspepsia remains to be proven to be of clinical value. (medscape.com)
- The benefit of treatment to eradicate H. pylori in functional dyspepsia remains controversial ( 3 , 4 ). (cdc.gov)
- Acid suppression improves dyspepsia symptoms but the efficacy of vonoprazan for functional dyspepsia remains unclear. (bvsalud.org)
- The effect of Helicobacter pylori (H pylori) eradication therapy in functional dyspepsia (FD) patients was inconsistent in previously published randomized controlled trials. (nih.gov)
- The prevalence of Helicobacter pylori infection was studied in 138 patients with dyspepsia in a hospital in Nakuru, Kenya, and in 138 asymptomatic sex- and age-matched controls from the same population. (cdc.gov)
- Many causes of dyspepsia exist, including Helicobacter pylori . (cdc.gov)
- The aim of this study was to investigate the role of H. pylori and its virulence genotypes in gastrointestinal diseases in Kenyan patients with dyspepsia . (bvsalud.org)
- H. pylori seropositivity was associated with dyspepsia after adjusting for age, sex, and residence (urban or rural). (cdc.gov)
- Among adults, the association between H. pylori infection and dyspepsia remained after adjusting for the above factors and for educational attainment, family size, and manual occupation. (cdc.gov)
- However, young persons with dyspepsia had an unexpectedly high prevalence of H. pylori infection. (cdc.gov)
- Thus, a noninvasive H. pylori test-and-treat strategy in a primary care setting in an economically depressed area, such as Africa, should be based on data that show an association between dyspepsia and H. pylori infection. (cdc.gov)
- The aim of our case-control study was to investigate the association between H. pylori infection and dyspepsia in Nakuru, Kenya. (cdc.gov)
- In addition, for the past 3 months, she has had severe postprandial dyspepsia that is not relieved by antacids. (medscape.com)
- Patients were also classified retrospectively into those with 'reflux-like' dyspepsia (n = 29) and those with 'motility-like' dyspepsia (n = 32). (nih.gov)
- Functional dyspepsia is a diagnosis of exclusion made in patients with chronic persistent epigastric pain in whom a thorough evaluation shows no organic disease. (medscape.com)
- Dyspepsia in the control group was excluded by clinical interview and a structured screening questionnaire. (cdc.gov)
- Although the term 'dyspepsia' is widely used in the medical literature, it has been variably interpreted by clinicians and investigators alike. (medscape.com)
- This continued lack of progress in the area can only lead one to question some very basic concepts in this disorder, such as does functional dyspepsia, as we have come to know it, really exist as a distinct entity? (medscape.com)